IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 2 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,205,000 | $8,351,000 | 3.49% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 622,744 | $4,316,000 | 1.61% |
| MARATHON CAPITAL MANAGEMENT | 25,000 | $173,000 | 0.09% |
| Granite Investment Partners, LLC | 125,251 | $868,000 | 0.08% |
| REGIONS FINANCIAL CORP | 30,500 | $211,000 | 0.00% |
| CIBC Private Wealth Group, LLC | 29,297 | $203,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 576 | $4,000 | 0.00% |
| Formidable Asset Management, LLC | 300 | $2,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,211 | $8,000 | 0.00% |
| CITIGROUP INC | 25 | $0 | 0.00% |